|
1
|
Rikova K, Guo A, Zeng Q, et al: Global
survey of phosphotyrosine signaling identifies oncogenic kinases in
lung cancer. Cell. 131:1190–1203. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee HJ, Xu X, Kim H, et al: Comparison of
direct sequencing, PNA clamping-real time polymerase chain
reaction, and pyrosequencing methods for the detection of EGFR
mutations in non-small cell lung carcinoma and the correlation with
clinical responses to EGFR tyrosine kinase inhibitor treatment.
Korean J Pathol. 47:52–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stenbygaard LE, Sørensen JB, Larsen H and
Dombernowsky P: Metastatic pattern in non-resectable non-small cell
lung cancer. Acta Oncol. 38:993–998. 1999. View Article : Google Scholar
|
|
5
|
Amin N and Vincan E: The Wnt signaling
pathways and cell adhesion. Front Biosci (Landmark Ed). 17:784–804.
2012. View Article : Google Scholar
|
|
6
|
Iwatsuki M, Mimori K, Yokobori T, et al:
Epithelial-mesenchymal transition in cancer development and its
clinical significance. Cancer Sci. 101:293–299. 2010. View Article : Google Scholar
|
|
7
|
Mei XD, Su H, Song J and Dong L:
Prognostic significance of β-catenin expression in patients with
non-small cell lung cancer: a meta-analysis. Biosci Trends.
7:42–49. 2013.PubMed/NCBI
|
|
8
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
11
|
Barker N and Clevers H: Catenins, Wnt
signaling and cancer. Bioessays. 22:961–965. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bienz M and Clevers H: Linking colorectal
cancer to Wnt signaling. Cell. 103:311–320. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peifer M and Polakis P: Wnt signaling in
oncogenesis and embryogenesis - a look outside the nucleus.
Science. 287:1606–1609. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
You Z, Saims D, Chen S, et al: Wnt
signaling promotes oncogenic transformation by inhibiting
c-Myc-induced apoptosis. J Cell Biol. 157:429–440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang CL, Liu D, Ishikawa S, et al: Wnt1
overexpression promotes tumour progression in non-small cell lung
cancer. Eur J Cancer. 44:2680–2688. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu X, Sun PL, Li JZ, Jheon S, Lee CT and
Chung JH: Aberrant Wnt1/β-catenin expression is an independent poor
prognostic marker of non-small cell lung cancer after surgery. J
Thorac Oncol. 6:716–724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu HT, Wang L, Lin D, et al: Abnormal
beta-catenin and reduced axin expression are associated with poor
differentiation and progression in non-small cell lung cancer. Am J
Clin Pathol. 125:534–541. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kase S, Sugio K, Yamazaki K, Okamoto T,
Yano T and Sugimachi K: Expression of E-cadherin and beta-catenin
in human non-small cell lung cancer and the clinical significance.
Clin Cancer Res. 6:4789–4796. 2000.
|
|
19
|
Travis WD, Brambilla E, Muller-Hermelink
HK and Harris C: Tumours of the lung, pleura, thymus and heart
Pathology and genetics. World Health Organization Classification of
Tumours. IARC Press; Lyon, France: 2004
|
|
20
|
Travis WD, Brambilla E, Noguchi M, et al:
International association for the study of lung cancer/american
thoracic society/european respiratory society international
multidisciplinary classification of lung adenocarcinoma. J Thorac
Oncol. 6:244–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bigin S, Yilmaz A, Ozdemir F, et al:
Extrathoracic staging of non-small cell bronchogenic carcinoma:
relationship of the clinical evaluation to organ scans.
Respirology. 7:57–61. 2002. View Article : Google Scholar
|
|
22
|
Wood SL, Pernemalm M, Crosbie PA and
Whetton AD: The role of the tumor-microenvironment in lung
cancer-metastasis and its relationship to potential therapeutic
targets. Cancer Treat Rev. 40:558–566. 2014. View Article : Google Scholar
|
|
23
|
Kremer M, Quintanilla-Martinez L, Fuchs M,
et al: Influence of tumor-associated E-cadherin mutations on
tumorigenicity and metastasis. Carcinogenesis. 24:1879–1886. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bongiorno PF, al-Kasspooles M, Lee SW, et
al: E-cadherin expression in primary and metastatic thoracic
neoplasms and in Barrett’s oesophagus. Br J Cancer. 71:166–172.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li XQ, Yang XL, Zhang G, et al: Nuclear
β-catenin accumulation is associated with increased expression of
Nanog protein and predicts poor prognosis of non-small cell lung
cancer. J Transl Med. 11:1142013. View Article : Google Scholar
|
|
26
|
Mitselou A, Batistatou A, Nakanishi Y,
Hirohashi S, Vougiouklakis T and Charalabopoulos K: Comparison of
the dysadherin and E-cadherin expression in primary lung cancer and
metastatic sites. Histol Histopathol. 25:1257–1267. 2010.PubMed/NCBI
|
|
27
|
Ohishi Y, Oda Y, Kurihara S, et al:
Nuclear localization of E-cadherin but not beta-catenin in human
ovarian granulosa cell tumours and normal ovarian follicles and
ovarian stroma. Histopathology. 58:423–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang L, Cheng H, Liu Y, et al: Prognostic
value of nuclear β-catenin overexpression at invasive front in
colorectal cancer for synchronous liver metastasis. Ann Surg Oncol.
18:1553–1559. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Geyer FC, Lacroix-Triki M, Savage K, et
al: β-Catenin pathway activation in breast cancer is associated
with triple-negative phenotype but not with CTNNB1 mutation. Mod
Pathol. 24:209–231. 2011. View Article : Google Scholar
|
|
30
|
Kim H, Yoo SB, Sun P, et al: Alteration of
the E-Cadherin/β-Catenin complex is an independent poor prognostic
factor in lung adenocarcinoma. Korean J Pathol. 47:44–51. 2013.
View Article : Google Scholar : PubMed/NCBI
|
